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ABSTRACT
A prospective, observational study was conducted in a medico-surgical intensive care unit to assess the
value of C-reactive protein (CRP), temperature and white cell count (WCC) measurements for the
diagnosis of infection in critically ill patients. CRP, temperature and WCC were monitored daily in 76
infected and 36 non-infected patients. Multiple receiver-operating characteristics (ROC) curves were
used to compare each parameter for infection diagnosis. The area under the curve (AUC) of CRP was
significantly higher than that of temperature (0.93 and 0.75, respectively; p < 0.001). A CRP
concentration of >8.7 mg ⁄dL and a temperature of >38.2C were associated with infection, with a
sensitivity of 93.4% and 54.8%, and a specificity of 86.1% and 88.9%, respectively. The ROC curve of
WCC showed a poor diagnostic performance. The combination of CRP and temperature increased the
specificity for infection diagnosis to 100%. In the subgroup of patients with ventilator-associated
pneumonia (n = 48), CRP measurements were more reliable than temperature (AUC 0.92 and 0.78,
respectively; p 0.006). The CRP levels in infected patients with sepsis, severe sepsis and septic shock
were 15.2 ± 8.2, 20.3 ± 10.9 and 23.3 ± 8.7 mg ⁄dL, respectively (p 0.044). It was concluded that CRP was
a better marker of infection than temperature. However, the combination of CRP and temperature
measurements further increased the specificity for infection diagnosis, even in the subgroup of patients
with VAP.
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INTRODUCTION
Manifestations of sepsis, such as fever, leukocy-
tosis and tachycardia, are quite sensitive, but
are not specific indicators of infection and can
be influenced by several non-infectious factors
[1]. A diagnosis of sepsis can only be strongly
suspected in the absence of confirmation by a
positive culture, but such confirmation may be
difficult to obtain [2]. The observation that non-
infectious clinical syndromes can be associated
with sepsis-like symptoms makes the diagnosis
of sepsis even more complicated. Consequently,
antibiotics are often prescribed without a defin-
ite diagnosis of sepsis to avoid missing an
infection.
C-reactive protein (CRP) is a well-known bio-
chemical marker of inflammation, and has also
been shown to be involved in several immunolo-
gical functions [3–5]. The usefulness of CRP
measurements in the diagnosis of infection has
been studied previously in several clinical set-
tings [6], and various studies have suggested that
the CRP cut-off level for infection diagnosis is
between 5 and 10 mg ⁄dL [7–10].
Body temperature is probably one of the most
frequently measured parameters in patients
admitted to an intensive care unit (ICU). It is an
inexpensive, reproducible and non-invasive pro-
cedure, and is easy to measure. As a marker of
infection, temperature is specific, but not sensitive
[7,10], and fever can also be associated with non-
infectious clinical syndromes [6,11]. Despite these
limitations, body temperature is an important
criterion in sepsis diagnosis [12].
Only a few studies have assessed the value of a
single determination of CRP in comparison
Correspondence: P. Po´voa, Unidade de Cuidados Intensivos,
Hospital Garcia de Orta, Avenue. Prof Torrado da Silva, 2800–
252 Almada, Portugal
E-mail: povoap@netcabo.pt
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
with other commonly used markers, such as
temperature and white cell count (WCC), for the
diagnosis of infection in an ICU setting. The
present study analysed the potential benefit of
combining CRP levels with temperature meas-
urements for the diagnosis of infection, and also
assessed the relationship between CRP levels
and the severity of sepsis. Finally, a secondary
analysis was performed to assess the value of
measuring CRP levels in the diagnosis of venti-
lator-associated pneumonia (VAP).
MATERIALS AND METHODS
This was a prospective observational cohort study from
November 2001 to December 2002. The ICU was an eight-
bed ward harbouring a mixed population of medical, surgical
and trauma patients. All patients who were aged ‡18 years
were enrolled consecutively. Patients with severe hepatic
failure were excluded from the study. The Hospital Ethics
Committee approved the study design; informed consent was
waived as there was no need for additional blood samples.
Data collected included admission diagnosis, past medical
history, vital signs, the severity of sepsis, defined according to
the ACCP ⁄ SCCM Consensus Conference [12] and the Sequen-
tial Organ Failure Assessment (SOFA) score [13]. CRP and
WCC were measured at admission and then daily until ICU
discharge or death. Temperature was recorded hourly and
daily extreme values were collected. Patients were evaluated
daily for clinical evidence of infection; samples for bacterio-
logical culture were collected whenever there was clinical
suspicion of infection.
Infected and non-infected patients were included in the
study. Infected patients were those with a defined source of
infectionwho yielded positive cultures (blood, bronchoalveolar
lavage, cerebrospinal fluid, pleural fluid, peritoneal fluid). For
the purposes of subgroup analysis, VAP was defined as a new
and persistent radiographic infiltrate, with at least two of the
following criteria: (i) temperature >38C or <36C; (ii)
WCC > 10 or < 4 · 103 ⁄mm3; (iii) purulent tracheal aspirate
[14]. All patients with documented infections commenced
empirical antibiotic therapy on the day of bacteriological
cultures. When bacteriological results became available, antibi-
otics were changed according to the pathogen isolated and the
antimicrobial susceptibility test results. Non-infected patients
had no bacteriological or clinical signs of infection and did not
receive antibiotics during their ICU stay. Patients with a clinical
suspicion of infection who received antibiotic therapy, but who
yielded negative cultures, were excluded from the analysis [8].
For infected and VAP patients, the day of comparison was
defined as the day cultures were taken and, for the purposes of
analysis, the CRP,WCCand the highest temperature of that day
were recorded. For non-infected patients, the day of comparison
was defined as the day of ICU admission, and theWCC and the
highest temperature of the day were recorded. Because of the
biology of CRP, the CRP level recorded in non-infected patients
was the highest level observed in the first 48 h after admission
[15–17]. On the day for comparison of infected and non-infected
patients, only one value of each parameter (CRP, temperature
and WCC) was analysed for each patient.
Blood samples were obtained from an arterial line on
admission, and subsequently each morning at 0700 h. Meas-
urement of CRP was by an immunoturbidimetric method with
a commercially available kit (Tina-quant CRP; Roche Diagnos-
tics, Mannheim, Germany).
Statistical analysis
Continuous variables were expressed as means ± SD unless
stated otherwise. Comparisons between groups were per-
formed with unpaired Student’s t-test, one-way ANOVA, Mann–
Whitney U or Kruskal–Wallis H-tests for continuous variables
according to data distribution. Post-hoc multiple comparisons
were performed with the Bonferroni test. v-square tests were
used to carry out comparisons between categorical variables.
Whenever Cochran’s assumptions were not met, an analysis of
standardised residuals was used to compare categorical
variables [18]. The correlation coefficient (r) or the Spearman
rank correlation (rs) were used to determine the relationship
between two variables, according to the characteristics of the
variables, i.e., numerical or ordinal. Receiver operating char-
acteristics (ROC) curves and the respective areas under the
curves (AUC) were calculated. Comparison of the AUC for
two variables was performed with the Hanley and McNeil
method [19,20]. The significance level was p < 0.05.
RESULTS
Of the 260 patients admitted to the ICU during
the study period, 76 infected and 36 non-infected
consecutive patients were included in the study.
Demographic characteristics of the patient popu-
lations are shown in Table 1. The distribution of
admission diagnoses was significantly different
(p 0.005) between the groups. The ICU mortality
rate among the infected patients was 39%, com-
pared with 16% in the non-infected group
(p 0.016). Infection was mostly (89%) caused by
Table 1. Characteristics of the patient population studied
Infected Non-infected p
Total, n 76 36
Age, years (mean ± SD) 59.4 ± 15.6 52.9 ± 20.7 0.068
Sex (M ⁄ F) 49 ⁄ 27 20 ⁄ 16 0.409
APACHE II (mean ± SD) 21.3 ± 6.3 19.8 ± 10.9 0.349
SOFA (mean ± SD) 7.9 ± 3.3 6.2 ± 3.4 0.019
Mechanical ventilation, n (%) 60 (79) 27 (75) 0.635
LOS, median (IQR) 19.5 (22) 5 (3) <0.001
Diagnosis 0.005
Cardiovascular 9 9
Respiratory 26 6
Gastrointestinal 1 0
Neurological 7 5
Endocrine 2 1
Obstetrics 0 5
Oncology 4 0
Alcoholism and drug abuse 2 3
Trauma 10 5
Surgery 15 2
Mortality, n (%) 30 (39) 6 (16) 0.016
APACHE II, Acute Physiology and Chronic Health Evaluation score; IQR,
interquartile range; LOS: length of stay; SD, standard deviation; SOFA, Sequential
Organ Failure Assessment score at the day of comparison.
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bacteria, with fungi involved in nine cases
(Table 2); the infection was polymicrobial in eight
cases. The distribution of infection sites is shown
in Table 3.
On the day of comparison (Fig. 1), the median
(interquartile range) plasma CRP concentration in
infected and non-infected patients was 19.1 (14.3)
and 4 (6.5) mg ⁄dL, respectively (p < 0.001). The
body temperature of infected patients was also
significantly higher than that of non-infected
patients (38.4 ± 1.1 and 37.4 ± 0.8C, respectively;
p < 0.001). TheWCC values were equally elevated
in the infected and non-infected groups (14.3 ± 7.9
and 14.1 ± 8 · 103 ⁄mm3, respectively; p 0.86).
On the day of comparison, the area under the
ROC curve of CRP was 0.93 (95% confidence
interval (CI), 0.87–0.99), and of temperature was
0.75 (95% CI 0.66–0.84), whereas the AUC of
WCC was 0.49 (95% CI 0.37–0.6) (Fig. 2). The
AUC of CRP was significantly higher than that of
temperature and WCC (p < 0.001 and p < 0.001,
respectively), and the AUC of temperature was
significantly higher than that of WCC (p < 0.001).
The best cut-off value for CRP was 8.7 mg ⁄dL,
and for temperature was 38.2 C (Table 4). Serum
CRP concentrations were >8.7 mg ⁄dL in 93.4% of
infected patients, but in only 13.9% of non-
infected patients (p < 0.001). The body tempera-
ture was above the cut-off of 38.2 C in 54.8% of
infected patients, but in only 11.1% of non-
infected patients (p < 0.001). The combination of
CRP and temperature increased the specificity for
infection diagnosis to 100% (Table 4).
In the subpopulation of VAP patients (n = 48),
the median (interquartile range) CRP concentra-
tionwas 19.6 (13.3)mg ⁄dL,whichwas significantly
higher than that of non-infected patients
(p < 0.001). The same was true for temperature
Table 2. Microbiological causes of infection among the
patients studied
Organism n
Gram-positive bacteria 35
Staphylococcus spp. 25
S. aureus 15
Coagulase-negative staphylococci 10
Streptococci 6
Group A 1
S. pneumoniae 4
viridans group 1
Enterococcus faecalis 4
Gram-negative bacteria 40
Pseudomonas aeruginosa 20
Serratia marcescens 4
Escherichia coli 4
Haemophilus influenzae 3
Citrobacter koseri 1
Klebsiella oxytoca 1
Klebsiella pneumoniae 1
Stenotrophomonas maltophilia 1
Proteus mirabilis 1
Mycoplasma pneumoniae 1
Morganella morganii 1
Moraxella catarrhalis 1
Neisseria meningitidis 1
Fungi 9
Candida spp. 9
Table 3. Primary sites of infection
Site of infection n
Respiratory 50
Blood 11
Gastrointestinal 8
Central nervous system 3
Skin and soft tissue 3
Cardiovascular system 1
infectednon-infected
CR
P 
(m
g/d
L)
50
40
30
20
10
0
infectednon-infected
Te
m
pe
ra
tu
re
 (º
C)
42
41
40
39
38
37
36
35
34
P < 0.001  
P < 0.001  
Fig. 1. C-reactive protein (CRP) (top) and temperature
(bottom) of infected (n = 76) and non-infected (n = 36)
patients. Graphs appear as box-plots with extreme values
and interquartile range.
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(38.4 ± 0.9 C on the day of diagnosis; p < 0.001).
The WCC was 13.9 ± 7 · 103 ⁄mm3, and was not
statistically different (p 0.72) from that of non-
infected patients. The area under theROCcurve for
CRP was 0.92 (95% CI 0.86–0.98), which was
significantly higher than for temperature (0.78;
95% CI 0.68–0.88; p 0.006). ACRP concentration of
>9.6 mg ⁄dL and a temperature >38.1 C were
associated with infection, with a sensitivity of
87.5% and 59.6%, and a specificity of 86.1% and
83.3%, respectively. The combination of CRP and
temperature increased the specificity for VAP
diagnosis to 100%, but with a sensitivity of
52.1%. The ROC curve of WCC showed a poor
diagnostic performance.
The influence of the severity of the critical illness
was assessed in relation to its origin, i.e., infectious
or non-infectious, CRP levels (Fig. 3) and SOFA
score. Infected and non-infected patients were
divided into four clinical groups according to the
ACCP ⁄ SCCM Consensus Conference criteria [12],
namely those with absence of the systemic inflam-
matory response syndrome (no-SIRS), those with
SIRS, those with severe sepsis, and those with
shock. Among non-infected patients, only two
presented with no-SIRS, 21 had SIRS, four had a
severe sepsis-like syndrome, and nine had shock,
with admission CRP concentrations of 3.1 ± 3,
2.5 ± 3.1, 2.8 ± 2.9 and 5.4 ± 7.7 mg ⁄dL, respect-
ively (p 0.884). The CRP concentrations in infected
patients with sepsis (n = 12), severe sepsis (n = 26)
and septic shock (n = 33) were 15.2 ± 8.2,
20.3 ± 10.9 and 23.3 ± 8.7 mg ⁄dL, respectively
(p 0.044). The CRP levels in patients with septic
shock were significantly higher than those in
patients with sepsis (p 0.041). On each level of
clinical severity, the CRP concentration in non-
infected patients was significantly lower than in
infected patients (p < 0.001). Nevertheless, non-
infected patients with SIRS and shock had SOFA
scores similar to those of infected patients with
equivalent clinical severity, namely 4.2 ± 1.8 and
4.5 ± 2.0 (p 0.53) and 11.1 ± 2.2 and 10.6 ± 3.1
(p 0.46), respectively.
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Fig. 2. Receiver operating characteristics (ROC) curves of
C-reactive protein (CRP) (solid line), temperature (dashed
line) and white cell count (WCC) (dotted line) in the
diagnosis of infection. The area under the curve for CRP
was significantly higher than that for temperature and
WCC (p < 0.001).
Table 4. Sensitivity and specificity for infection diagnosis
of C-reactive protein (CRP), body temperature, and CRP
combined with body temperature
CRP
(cut-off 8.7 mg/dL)
Temperature
(cut-off 38.2C) CRP + temperature
Sensitivity 93.4 54.8 50
Specificity 86.1 88.9 100
PPV 93.4 91.3 100
NPV 86 48.2 48.6
PPV, positive predictive value; NPV, negative predictive value.
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Fig. 3. Influence of the origin (i.e., infectious or non-
infectious) and severity of the critical illness on CRP levels.
Infected and non-infected patients were divided into four
clinical groups according to the ACCP ⁄ SCCM Consensus
Conference criteria [12], namely absence of the systemic
inflammatory response syndrome (no-SIRS), SIRS, severe
sepsis, and shock. In each degree of clinical severity,
infected patients had a significantly higher CRP level than
non-infected patients (*p < 0.001) .
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In infected patients, the relationship between
CRP values and the severity of sepsis was
studied. A reasonable correlation was found
between the severity of sepsis and CRP concen-
trations rs = 0.32, r
2
s = 0.1; p 0.007). In addition,
when the association between CRP levels and the
degree of organ failure was evaluated, a relation-
ship was found between the CRP concentrations
of infected patients and the SOFA score (r = 0.34,
r2 = 0.12; p 0.004).
DISCUSSION
This study of a typical heterogeneous ICU patient
population suggested that the CRP concentration
is a good marker of infection diagnosis, and that it
performs better than body temperature and WCC
measurements. The combination of CRP and
temperature measurements further increased the
specificity for the diagnosis of infection. Equival-
ent results were obtained in the subpopulation of
patients with VAP. The comparison of the diag-
nostic performance of CRP, temperature and
WCC for infection diagnosis was performed by
dividing the patients into three groups [21]: (i)
those with documented infection; (ii) those with-
out infection who did not receive antibiotics
during their ICU stay; and (iii) those with suspi-
cion of infection who received antibiotics for a
possible infection. The latter group was excluded
from analysis, since the diagnosis of infection was
uncertain [8]. With this methodology, the cut-off
value of CRP for diagnosis of infection and VAP
was 8.7 and 9.6 mg ⁄dL, respectively, both with
good sensitivity and specificity.
Previous studies using the same methodology
have yielded similar results [8,22–24], but con-
flicting results have been reported using different
approaches and methodologies [25–28]. Most of
these reports used the ACCP ⁄ SCCM Consensus
Conference criteria to define the presence or
absence of sepsis and to divide the patient
population into different subgroups [12]. How-
ever, this methodology has some drawbacks,
since all four SIRS criteria are influenced by
numerous non-infectious conditions [7,10,29,30].
Consequently, SIRS without infection is found
frequently, particularly among critically ill pa-
tients [31–33]. Therefore, dividing the patients
according to ACCP ⁄ SCCM Consensus Confer-
ence criteria, instead of on the basis of documen-
ted infection vs. no infection and no antibiotic
prescription, would result in different findings
and conclusions. A marker of infection should
allow a distinction between the presence and the
absence of an infection. Using the Consensus
Conference criteria alone to divide the patients
into groups could result in an assessment of a
marker’s ability to identify degrees of clinical
severity rather than a marker’s diagnostic per-
formance for infection per se [1].
The origin of the critical illness, i.e., infectious or
non-infectious, was shown to have a marked
influence on CRP concentration, independently
of disease severity, as shown in Fig. 3. Non-
infected patients had low CRP concentrations on
admission, even if they had shock syndrome;
however, these concentrations were higher than
the normal range of a healthy population, prob-
ably reflecting some ongoing inflammatory pro-
cess. In contrast, CRP levels were significantly
higher in infected patients across the different
clinical severity groups, with a reasonable rela-
tionship between the CRP levels and the severity
of sepsis, as reported previously [8,22,23]. SOFA
scores were similar in infected and non-infected
patients with equivalent disease severity, but
higher SOFA scores in infected patients were
associated with increased CRP levels, suggesting
ongoing inflammatory activity. A reasonable rela-
tionship between CRP concentrations and organ
failure has been reported previously [4,7]. The
concentration of CRP in the healthy population
has a median of 0.08 mg ⁄dL [15,16], but is fre-
quently higher than the normal range of the
healthy population in critically ill non-infected
patients (Fig. 3) [34]. Such minor CRP elevations
could be the result of the underlying non-
infectious disease process.
Even though body temperature is one of the
most frequently measured parameters in the ICU
setting, the ‘normal’ temperature in the healthy
population is still a matter of debate [35]. How-
ever, the definition of fever proposed by the
Consensus Conference on Sepsis is a body tem-
perature of >38C, irrespective of the measure-
ment site, time of day or age of the patient [12].
Although readily available, inexpensive and non-
invasive, body temperature is a poor indicator of
infection. In the critical care setting, particularly
in the post-operative period, fever is frequently
not caused by an infection [32,36], and the
severity of the febrile response is not an indication
of the severity of an infection. Nevertheless, in the
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present study, temperature appeared to have a
reasonably good performance for the diagnosis of
infection and VAP, with an AUC of 0.75 and 0.78,
respectively. The best temperature cut-off values
for infection and VAP diagnosis were 38.2 and
38.1C, respectively. The combination of CRP plus
temperature measurements was much more spe-
cific in diagnosing infection and VAP, increasing
the specificity to 100% in both clinical situations.
In the present study, all the patients with CRP
values and body temperature above the prede-
fined cut-offs were classified correctly as infected.
Several reports have suggested that procalcito-
nin (PCT) should replace CRP as a marker of
infection in the ICU setting [25,28]. However, well-
designed studies have shown that PCT is neither a
better nor earlier marker of infection diagnosis
than CRP [8,22,37], and in some clinical situations
of infectious origin commonly found in ICUs, PCT
can be normal or even undetectable [9,23,38]. In
certain situations [39], PCT has been reported to be
superior to CRP in discriminating infectious epi-
sodes, but the currently proposed PCT cut-off
level of <1.0 ng ⁄mL for infection diagnosis [40]
may need to be refined further. It has been shown
that the combination of PCT and CRP further
increases the specificity for infection diagnosis [8],
and it is well-established that levels of PCT rise
with increasing severity of the inflammatory
response to infection [8,9,22]. The behaviour of
PCT in acute renal failure is still unknown [22], but
it has been demonstrated that renal replacement
therapy has a significant effect on PCT levels [41].
To improve the diagnostic accuracy for infec-
tion in ICUs, various scoring systems have been
developed, including the Clinical Pulmonary
Infection Score (CPIS) for VAP [42] and the
Infection Probability Score (IPS) for prediction of
infection [43]. Both scores are combinations of
clinical and laboratory signs, and the CPIS also
includes microbiological criteria. The cut-off and
weight of each variable included in the CPIS was
set empirically, and a score of >6 had a sensitivity
of 0.93 for detection of VAP in the original paper
[42]. However, the diagnostic accuracy of the
CPIS has been challenged [44,45]. In the IPS [43],
the cut-off and weight of each variable included
in the score was set by logistic regression analysis.
An IPS of 14 had a positive predictive value of
53.6% and a negative predictive value of 89.5%.
The final IPS model integrated six variables,
namely temperature, heart rate, respiratory rate,
WCC, CRP and SOFA score. Three of these
variables (respiratory rate, WCC and SOFA) were
forced in the final model, although they were not
associated significantly with infection. The other
three variables, namely heart rate, CRP and body
temperature, had the highest predictive values of
infection. The present study only investigated
three of these variables (CRP, temperature and
WCC), but obtained similar results. WCC was a
very poor indicator, but both CRP and body
temperature measurements were found to be
associated strongly with the diagnosis of infection
in critically ill patients, and even more so when
used in combination. Heart rate could be influ-
enced by a number of non-infectious factors, so
surrogate markers of an inflammatory response,
such as CRP and body temperature, could be
much more useful in daily clinical practice as
their interpretation is quite straightforward with-
out the need to calculate a score [46].
Laboratory tests for CRP are available readily in
almost every hospital and are less costly than other
cytokine determinations [4,47]. To our knowledge,
the present study is the first to detail the usefulness
of the combinationofCRPandbody temperature in
the diagnosis of infection and VAP in critically ill
patients. If the CRP concentration is >8.7 mg ⁄dL, a
diagnosis of infection is further supported by a
body temperature of >38.2C.
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